Global Growth Hormone Deficiency Market Size, Forecast, and Trend Highlights Over 2025-2037
Growth Hormone Deficiency Market size was valued at USD 4.4 billion in 2024 and is projected to reach USD 9.3 billion by the end of 2037, rising at a CAGR of 7.3% during the forecast period, i.e., 2025 to 2037. In 2025, the industry size of GHD is estimated at USD 4.6 billion.
The global growth hormone deficiency market is witnessing tremendous expansion opportunities owing to the rising diagnostic rates, increased applications in pediatric and adult growth hormone disorder treatment. In this context NIH report in 2024 reported that nearly 1.3 million growth hormone deficiency cases are being noted in a year, with pediatric cases holding more than 55% of cases due to congenital and idiopathic causes. This expanding patient pool necessitates the need for appropriate management strategies to mitigate complications in the long run.
Furthermore, the augmentation in the growth hormone deficiency market is appreciably influenced by trade and economic activities. For instance, in 2024, BLS reported that the PPI and CPI of GHD therapeutics increased by 4.5% and 7.4% due to the growing raw material costs and reimbursement delays. Besides, the exports of GHD-associated goods are significantly dominated by the U.S. and EU, with more than 75% of goods. Meanwhile, the imports are led by Brazil and India. Therefore, this is the evidence for a wider market scope with commendable growth opportunities.
